Market Place
Sourcing Support
All News #Library
Biotech
BioMarin Completes Inozyme Acquisition
01 Jul 2025 //
PR NEWSWIRE
BioMarin Inks $270M Inozyme buyout, phase 3 prospect
17 May 2025 //
PRESS RELEASE
Inozyme To Present INZ-701 Data For ENPP1 Deficiency At CHOP 2025
21 Feb 2025 //
GLOBENEWSWIRE
Inozyme Reports Positive Data For INZ-701 In ENPP1 Deficiency
10 Jan 2025 //
GLOBENEWSWIRE
Inozyme Pharma Shares Positive Phase 1 SEAPORT 1 Data
24 Oct 2024 //
GLOBENEWSWIRE
Inozyme Pharma Presents New Data At ASBMR 2024 Annual Meeting
26 Sep 2024 //
GLOBENEWSWIRE
Inozyme Announces Positive Data from Ph 1/2 Trials of INZ-701 in Adults
08 Apr 2024 //
GLOBENEWSWIRE
Inozyme to Report Data from Ongoing Phase 1/2 Trials of INZ-701
26 Mar 2024 //
GLOBENEWSWIRE
Inozyme Highlights Inclusion of GACI in Genomics England™s Generation Study
10 Oct 2023 //
GLOBENEWSWIRE
Inozyme Announces Positive Interim Data from Ongoing Phase 1/2 Trials of INZ-701
26 Sep 2023 //
GLOBENEWSWIRE
Inozyme Reports Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701
16 Feb 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.